Huy Anh Tran

Summary

Affiliation: New South Wales
Country: Australia

Publications

  1. pmc The reduced predictive value of interleukin 28b gene polymorphisms in a cohort of patients with thyroiditis developed during antiviral therapy for chronic hepatitis C: a preliminary study
    Huy A Tran
    Hunter Area Pathology Service, John Hunter Hospital, Newcastle, Australia
    Hepat Mon 12:e6036. 2012
  2. pmc The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon-alpha Therapy for Chronic Hepatitis C
    Huy A Tran
    Hunter Area Pathology Service, Hunter Mail Region Centre, John Hunter Hospital, Locked Bag Number 1, Newcastle, NSW 2310, Australia
    Int J Endocrinol 2009:241786. 2009
  3. doi request reprint Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective
    Huy A Tran
    Department of Clinical Chemistry, Hunter Area Pathology Service, Newcastle, New South Wales, Australia
    Endocr Pract 19:292-300. 2013
  4. doi request reprint Thyroid function outcomes after pegylated interferon-α and ribavirin therapy for chronic hepatitis C
    Huy A Tran
    Division of Clinical Chemistry, Hunter Area Pathology Service, Newcastle, New South Wales 2310, Australia
    Endocr Pract 16:934-9. 2010
  5. doi request reprint Histopathologic findings of autoimmunity in thyroid, pituitary, and adrenal diseases in chronic hepatitis C postmortem cases
    Huy A Tran
    Hunter Area Pathology Service, Hunter Mail Region Centre, Newcastle, New South Wales, Australia
    Endocr Pract 16:566-9. 2010
  6. pmc The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study
    Huy A Tran
    Hunter Area Pathology Service and University of Newcastle, Locked Bag Number 1, Hunter Mail Region Centre, Newcastle, New South Wales 2310, Australia
    Thyroid Res 4:2. 2011
  7. pmc The influence of hepatitis C infection and interferon-alpha therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case report
    Huy A Tran
    Department of Clinical Chemistry and University of Newcastle, Locked Bag 1, Hunter Region Mail Centre, Newcastle, New South Wales 2310, Australia
    Thyroid Res 2:12. 2009
  8. pmc Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study
    Huy A Tran
    Hunter Area Pathology Service and University of Newcastle, Locked Bag Number 1, Hunter Mail Region Centre, Newcastle, New South Wales 2310, Australia
    BMC Endocr Disord 11:10. 2011
  9. doi request reprint Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis
    Huy Anh Tran
    Hunter Area Pathology Service, John Hunter Hospital, University of Newcastle, New South Wales, Australia
    J Gastroenterol Hepatol 24:1163-8. 2009
  10. doi request reprint Hepatitis C infection and thyrotoxic periodic paralysis--a novel use of an old drug
    Huy A Tran
    Hunter Area Pathology Service, John Hunter Hospital, Hunter Mail Region Centre, Newcastle, New South Wales, Australia
    Am J Med Sci 336:515-8. 2008

Detail Information

Publications28

  1. pmc The reduced predictive value of interleukin 28b gene polymorphisms in a cohort of patients with thyroiditis developed during antiviral therapy for chronic hepatitis C: a preliminary study
    Huy A Tran
    Hunter Area Pathology Service, John Hunter Hospital, Newcastle, Australia
    Hepat Mon 12:e6036. 2012
    ..Similarly, thyroid disease (TD) occurring during treatment confer an improved sustained virologic response (SVR)...
  2. pmc The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon-alpha Therapy for Chronic Hepatitis C
    Huy A Tran
    Hunter Area Pathology Service, Hunter Mail Region Centre, John Hunter Hospital, Locked Bag Number 1, Newcastle, NSW 2310, Australia
    Int J Endocrinol 2009:241786. 2009
    ..This paper suggests the need to continue thyroid surveillance in IFN-treated HCV patients following the completion of therapy, perhaps for the first 6 months...
  3. doi request reprint Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective
    Huy A Tran
    Department of Clinical Chemistry, Hunter Area Pathology Service, Newcastle, New South Wales, Australia
    Endocr Pract 19:292-300. 2013
    ..We also summarize the current understanding of the natural history of the condition and propose management and follow-up guidelines...
  4. doi request reprint Thyroid function outcomes after pegylated interferon-α and ribavirin therapy for chronic hepatitis C
    Huy A Tran
    Division of Clinical Chemistry, Hunter Area Pathology Service, Newcastle, New South Wales 2310, Australia
    Endocr Pract 16:934-9. 2010
    ..To assess the frequency of new thyroid disease, in patients who did not develop thyroid disease during treatment with interferon-α in combination with ribavirin for hepatitis C, during the 6-month period after the end of therapy...
  5. doi request reprint Histopathologic findings of autoimmunity in thyroid, pituitary, and adrenal diseases in chronic hepatitis C postmortem cases
    Huy A Tran
    Hunter Area Pathology Service, Hunter Mail Region Centre, Newcastle, New South Wales, Australia
    Endocr Pract 16:566-9. 2010
    ..To assess the histologic prevalence of immune-mediated thyroid, pituitary, and adrenal diseases in postmortem cases with hepatitis C...
  6. pmc The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study
    Huy A Tran
    Hunter Area Pathology Service and University of Newcastle, Locked Bag Number 1, Hunter Mail Region Centre, Newcastle, New South Wales 2310, Australia
    Thyroid Res 4:2. 2011
    ..The aim of the study is to determine the natural history of thyroid disease including antibody profile in this particular setting 36 months from the completion of therapy...
  7. pmc The influence of hepatitis C infection and interferon-alpha therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case report
    Huy A Tran
    Department of Clinical Chemistry and University of Newcastle, Locked Bag 1, Hunter Region Mail Centre, Newcastle, New South Wales 2310, Australia
    Thyroid Res 2:12. 2009
    ....
  8. pmc Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study
    Huy A Tran
    Hunter Area Pathology Service and University of Newcastle, Locked Bag Number 1, Hunter Mail Region Centre, Newcastle, New South Wales 2310, Australia
    BMC Endocr Disord 11:10. 2011
    ..abstract:..
  9. doi request reprint Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis
    Huy Anh Tran
    Hunter Area Pathology Service, John Hunter Hospital, University of Newcastle, New South Wales, Australia
    J Gastroenterol Hepatol 24:1163-8. 2009
    ..The present study investigated whether thyroid dysfunction while undergoing combination treatment for hepatitis C is a favorable prognostic maker for a sustained virological response...
  10. doi request reprint Hepatitis C infection and thyrotoxic periodic paralysis--a novel use of an old drug
    Huy A Tran
    Hunter Area Pathology Service, John Hunter Hospital, Hunter Mail Region Centre, Newcastle, New South Wales, Australia
    Am J Med Sci 336:515-8. 2008
    ..Initial treatment with beta-blocker failed to normalize his serum potassium concentration, requiring the novel use of spironolactone, despite euthyroidism. This continued to be required until his testosterone supplement dissipated...
  11. doi request reprint The natural history of interferon-alpha2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection
    H A Tran
    Hunter Area Pathology Service, Newcastle University, Newcastle, New South Wales 2310, Australia
    QJM 102:117-22. 2009
    ....
  12. pmc Exacerbation of hepatitis C induced subclinical hypoadrenalism by Interferon-alpha2beta: A case report
    Huy A Tran
    Department of Clinical Chemistry, Hunter Area Pathology Service, Locked Bag Number 1, Hunter Mail Region Centre, Newcastle, New South Wales 2310, Australia
    Cases J 1:157. 2008
    ..A number of possible pathogenic mechanisms are discussed, and the controversy over its management is emphasized...
  13. pmc Fulminant Clostridium Septicum myonecrosis in well controlled diabetes: a case report
    Huy A Tran
    Division of Clinical Chemistry Hunter Area Pathology Service, John Hunter Hospital, Locked Bag 1, Hunter Region Mail Centre, Newcastle, New South Wales, Australia 2310
    J Med Case Reports 1:119. 2007
    ..This highlights the opportunistic character of the organism and recommends that a high index of suspicion and vigilance be carried out in the presence of fevers and sepsis, even in the well-controlled diabetic population...
  14. ncbi request reprint Pegylated interferon-alpha2beta in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-alpha2beta in a hepatitis C population: meta-analysis
    Huy A Tran
    Hunter Area Pathology Service, Newcastle, New South Wales, Australia
    J Gastroenterol Hepatol 22:472-6. 2007
    ..The purpose of this study was to assess the risk of developing thyroid disease with pegylated IFN (pIFN) versus regular IFN (rIFN) therapy (in combination with RBV). We also pooled our results with previous studies in a meta-analysis...
  15. ncbi request reprint A 74-year-old woman with increasing dyspnea. Wet berberi with fulminant (Shoshin) cardiac failure and elevated troponin I
    Huy A Tran
    Hunter Area Pathology Services, Newcastle, New South Wales, Australia
    Arch Pathol Lab Med 130:e8-10. 2006
  16. ncbi request reprint Myxedema pseudovolvulus
    Huy A Tran
    Department of Clinical Chemistry, Hunter Area Pathology Service, John Hunter Hospital, Newcastle, New South Wales 2310, Australia
    J Clin Endocrinol Metab 91:2819-20. 2006
  17. ncbi request reprint Erlenmeyer flask
    Huy A Tran
    Department of Clinical Chemistry, Hunter Area Pathology Service, John Hunter Hospital, New South Wales 2310, Australia
    J Clin Endocrinol Metab 89:4827-8. 2004
  18. ncbi request reprint Test and teach. Number Fifty-three. Diagnosis: Diabetes-related dyslipidaemia
    Huy A Tran
    Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW, Australia
    Pathology 36:576-9. 2004
    ..Therapeutic options for acute and severe dyslipidaemia include insulin therapy, fibric acid derivatives, fish oils and, rarely, nicotinic acids. Hospitalisation may be required for plasmapheresis in specialised centres...
  19. ncbi request reprint Difficulties in diagnosing and managing coexisting primary hypothyroidism and resistance to thyroid hormone
    Huy A Tran
    Department of Clinical Chemistry, Hunter Area Pathology Service, John Hunter Hospital, New South Wales, Australia
    Endocr Pract 12:288-93. 2006
    ..To report a case of resistance to thyroid hormone compounded by autoimmune primary hypothyroidism and to discuss the unusual pattern of results of thyroid function tests...
  20. ncbi request reprint Gland handling
    Huy A Tran
    Department of Clinical Chemistry, Hunter Area Pathology Service, John Hunter Hospital and Newcastle University, New South Wales, Australia
    Am J Med 120:948-50. 2007
  21. ncbi request reprint Visual vignette: a case presentation
    Huy A Tran
    Hunter Area Pathology Service, John Hunter Hospital, New South Wales, Australia
    Endocr Pract 11:210. 2005
  22. ncbi request reprint After the bender
    Huy A Tran
    Department of Clinical Chemistry, Hunter Area Pathology Service, John Hunter Hospital and Newcastle University, Newcastle, New South Wales, Australia
    Am J Med 119:487-90. 2006
  23. ncbi request reprint The uncertain natural history of thyrotoxic patients treated with combination interferon alfa-2beta and ribavirin
    Huy A Tran
    Arch Intern Med 165:1072; author reply 1072-3. 2005
  24. ncbi request reprint Insulin measurement is also inappropriate in paediatric obesity
    Huy A Tran
    Med J Aust 186:270; author reply 271-2. 2007
  25. ncbi request reprint Management of obesity
    Huy A Tran
    Med J Aust 181:461-2; author reply 462. 2004
  26. ncbi request reprint Thyrotoxicosis during pegylated interferon therapy in a patient with chronic hepatitis C virus
    Huy A Tran
    Endocr Pract 12:231-2; author reply 232. 2006